SLC2A2 and type 1 diabetes mellitus: Current clinical studies revealed that T1D patients shared the common clinical features with other patients having autoimmune- and inflammation-associated diseases: (1) displaying the low or no expression of GLUT2 on PB-IPC at baseline; and (2) exhibiting a high profile of the inflammatory cytokine IL-1β.